![Avery Catlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Avery Catlin
Director/Miembro de la Junta en
Corbus Pharmaceuticals, Inc.
.
Perfil
Avery W.
Catlin is currently the Director at Corbus Pharmaceuticals, Inc. and the Vice President at CuraGen Corp.
Previously, he served as the Independent Director at Provention Bio, Inc. from 2018 to 2023 and at Corbus Pharmaceuticals Holdings, Inc. from 2014 to 2024.
He also held the position of Chief Financial Officer at MediSense, Inc. and Repligen Corp.
from 1992 to 1996 and Chief Financial Officer & VP-Operations at Endogen, Inc. from 1996 to 1999.
From 2000 to 2008, he was the Chief Financial Officer, Secretary & SVP at AVANT Immunotherapeutics, Inc. and from 2011 to 2017, he served as the CFO, Secretary, Treasurer & Senior Vice President at Celldex Therapeutics, Inc. Mr. Catlin completed his undergraduate degree at the University of Virginia and holds an MBA from Babson College.
Cargos activos de Avery Catlin
| Empresas | Cargo | Inicio |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | - |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Avery Catlin.
| Empresas | Cargo | Fin |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Director/Miembro de la Junta | 15/08/2024 |
| PROVENTION BIO, INC. | Director/Miembro de la Junta | 27/04/2023 |
| CELLDEX THERAPEUTICS, INC. | Director Financiero/CFO | 30/06/2017 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Director Financiero/CFO | 01/10/2008 |
Endogen, Inc.
 Endogen, Inc. Medical SpecialtiesHealth Technology Makes reagents & immuno-assay test kits | Director Financiero/CFO | 01/01/1999 |
Formación de Avery Catlin.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
50
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
MediSense, Inc.
 MediSense, Inc. Medical SpecialtiesHealth Technology Provides blood-glucose monitoring systems | Health Technology |
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Endogen, Inc.
Endogen, Inc. Medical SpecialtiesHealth Technology Makes reagents & immuno-assay test kits | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
- Bolsa de valores
- Insiders
- Avery Catlin
